Steroidal side effects of exemestane

Comment

J M Nabholtz. J Clin Oncol. 2001.

. 2001 Apr 1;19(7):2107-8.

doi: 10.1200/JCO.2001.19.7.2107.

No abstract available

Comment on

Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group.
Jones S, Vogel C, Arkhipov A, Fehrenbacher L, Eisenberg P, Cooper B, Honig S, Polli A, Whaley F, di Salle E, Tiffany J, Consonni A, Miller L. Jones S, et al. J Clin Oncol. 1999 Nov;17(11):3418-25. doi: 10.1200/JCO.1999.17.11.3418. J Clin Oncol. 1999. PMID: 10550136 Clinical Trial.
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
Kaufmann M, Bajetta E, Dirix LY, Fein LE, Jones SE, Zilembo N, Dugardyn JL, Nasurdi C, Mennel RG, Cervek J, Fowst C, Polli A, di Salle E, Arkhipov A, Piscitelli G, Miller LL, Massimini G. Kaufmann M, et al. J Clin Oncol. 2000 Apr;18(7):1399-411. doi: 10.1200/JCO.2000.18.7.1399. J Clin Oncol. 2000. PMID: 10735887 Clinical Trial.